UsAgainstAlzheimer’s (UsA2) has issued a Request for Information (RFI) to inform the technical design, development, and implementation of ADEA – the Alzheimer’s Disease Evidence Accelerator – a collaborative forum for experts and stakeholders to collect, curate, and analyze valid, reliable, and actionable real-world data to support decisions on the diagnosis and management of patients with Alzheimer’s disease, including benefits, risks and comparative effectiveness of new therapies. 

UsA2 welcomes data science experts and providers to respond to our RFI describing ADEA’s need for a data and analytics infrastructure to support its collaborative forum. Please review the RFI for more information.

Thank you to those who submitted questions about the RFI. The full list of questions and answers can be viewed here.

Responses to the RFI are due June 17, 2022, and should be sent to [email protected].